Trademark Overview
On Tuesday, April 10, 2007, a trademark application was filed for INSTAGEN with the United States Patent and Trademark Office. The USPTO has given the INSTAGEN trademark a serial number of 77152721. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, June 27, 2007. This trademark is owned by Pfizer Health AB. The INSTAGEN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, human growth hormones and accompanying drug delivery system
